Semiglutide & Ozempic Weight Loss

Initial consultation involves a comprehensive medical history review, including previous weight loss attempts, current medications, and screening for conditions that might contraindicate GLP-1 therapy. The physician assesses your BMI, discusses realistic weight loss goals, and explains how semaglutide or tirzepatide works differently from stimulant-based appetite suppressants.

Medical evaluation includes laboratory work such as comprehensive metabolic panel, HbA1c, lipid profile, and thyroid function tests. Some patients may need additional screening like an EKG or pregnancy test. This baseline data helps determine the safest starting dose and monitors for potential complications.

Personalized treatment planning considers your lifestyle, food preferences, injection comfort level, and insurance coverage to select between available GLP-1 options. The physician creates a dose escalation schedule typically spanning 16-20 weeks to reach therapeutic levels while minimizing side effects.

Medication initiation begins with the lowest dose, thorough injection training, and detailed instructions about timing with meals to reduce nausea. Patients receive emergency contact information and clear guidelines about when to seek medical attention for severe symptoms.

Ongoing monitoring occurs every 4-6 weeks initially, with dose increases based on tolerability and weight loss progress. The clinic tracks both beneficial effects and any concerning symptoms, adjusting treatment as needed.

Long-term maintenance involves quarterly visits once you reach your goal weight, focusing on sustaining results and preventing weight regain. The physician works with you to develop strategies for transitioning off medication if appropriate or continuing therapy for weight maintenance.